| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |